CSS
KIN

Cubist Systematic Strategies’s Kindred Biosciences, Inc. KIN Stock Holding History

Cubist Systematic Strategies’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,903
Closed -$39K – 3217
2021
Q1 		$39K Buy
+7,903
New +$38.2K ﹤0.01% 2746
2019
Q2 		– Sell
-11,659
Closed -$107K – 2656
2019
Q1 		$107K Buy
+11,659
New +$118K ﹤0.01% 1983

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Cubist Systematic Strategies's KIN Position: Q2 2021 in Review

Cubist Systematic Strategies sold out of Kindred Biosciences, Inc. (KIN) in Q2 2021, closing a stake of 7,903 shares — an estimated $39K sold.

Cubist Systematic Strategies first reported a position in KIN in Q1 2019 and held it in 2 quarters. The position peaked at $107K in Q1 2019. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

  • Cubist Systematic Strategies reported no remaining Kindred Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 7,903 Kindred Biosciences, Inc. shares in Q2 2021, an estimated $39K.
  • Cubist Systematic Strategies first reported a position in Kindred Biosciences, Inc. in Q1 2019 and held it in 2 quarters.
  • Cubist Systematic Strategies's Kindred Biosciences, Inc. position peaked at $107K in Q1 2019.
  • 87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.